A Novel Targeted Therapy System for Cervical Cancer: Co-Delivery System of Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier.
Hui YeXiaoying ChuZhensheng CaoXuanxuan HuZihan WangMeiqi LiLeyu WanYongping LiYongge CaoZhanqiu DiaoFengting PengJinsong LiuLihua XuPublished in: International journal of nanomedicine (2021)
The novel codelivery of OXA and MDC1-AS magnetic thermosensitive cationic liposome drug carrier can be applied in the combined chemotherapy and gene therapy for cervical cancer.